References
- Gefter WB, Weingrad TR, Epstein DM, Ochs RH, Miller WT. ‘Semi-invasive’ pulmonary aspergillosis: a new look at the spectrum of Aspergillus infections of the lung. Radiology 1981;140:313–21.
- Binder RE, Faling LJ, Pugatch RD, Mahasean C, Snider GL. Chronic necrotizing pulmonary aspergillosis: a discrete clinical entity. Medicine 1982;61:109–24.
- Denning DW, Riniotis K, Dobrashian R, Sambatakou H. Chronic cavitary and fibrosing pulmonary and pleural aspergillosis: case series, proposed nomenclature change, and review. Clin Infect Dis 2003;37:265–80.
- Staib F, Seibold M, Grosse M. Aspergillus findings in AIDS patients suffering from cryptococcosis. Mycoses 1989;32: 516–23.
- Saraceno JL, Phelps DT, Ferro TJ, Futerfas R, Schwartz DB. Chronic necrotizing pulmonary aspergillosis: approach to management. Chest 1997;112:541–8.
- Rosenheim SH, Schwarz J. Cavitary pulmonary cryptococcosis complicated by aspergilloma. Am Rev Respir Dis 1975; 111:549–53.
- Kato T, Usami I, Morita H, Goto M, Hosoda M, Nakamura A, Shima S. Chronic necrotizing pulmonary aspergillosis in pneumoconiosis. Chest 2002;121:118–27.
- Herbrecht R, Denning DW, Patterson TF, Bennett JE, Greene RE, Oestmann JW, et al. Invasive Fungal Infections Group of the European Organization for Research and Treatment of Cancer and the Global Aspergillus Study Group. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med 2002;347: 408–15.